Literature DB >> 30872068

Biotin interference in immunoassays based on biotin-strept(avidin) chemistry: An emerging threat.

John H T Luong1, Keith B Male2, Jeremy D Glennon3.   

Abstract

Biotinylated antibodies/antigens are currently used in many immunoassay formats in clinical settings for diversified analytes and biomarkers to offer high detection selectivity and sensitivity. Biotin cannot be synthesized by mammals and must be taken as an essential supplement. Normal intake of biotin from various foods and milk causes no effect on the streptavidin/biotin-based immunoassays. However, overconsumption of biotin (daily doses 100-300 mg) poses a significant problem for immunoassays using the biotin-strept(avidin) pair. Biotin interferences are noted in immunoassays of thyroid markers, drugs, hormones, cancer markers, the biomarker for cardiac function (β-human chorionic gonadotropin), etc. The biotin level required for serious interference in test results varies significantly from test to test and cannot easily be predicted. Immunoassay manufacturers with technologies based on strept(avidin)-biotin binding must investigate the interference from biotin (up to at least 1200 ng/mL or 4.9 μM of biotin) in various formats. There is no concrete solution to circumvent the biotin interference encountered in blood samples, short of biotin removal. Considering the short half-life of biotin in the human body, patients must stop taking biotin supplements for >48 h before the test. However, this scenario is not considered for patients in emergency situations or those with biotinidase deficiency, mitochondrial metabolic disorders or multiple sclerosis. Apparently, a rapid analytical procedure for biotin is urgently needed to quantify for its interference in immunoassays using strep(avidin)-biotin chemistry. To date, there is no quick and reliable procedure for the detection of biotin at below nanomolar levels in blood and biological samples. Traditional lab-based techniques including HPLC/MS-MS cannot process an enormous number of public samples. Biosensors with high detection sensitivity, miniaturization, low cost, and multiplexing have the potential to address this issue.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Avidin/streptavidin; Biotin interference; Biotin removal; Competitive assay; Falsely negative; Falsely positive; Immunoassays; Sandwiched assay

Year:  2019        PMID: 30872068     DOI: 10.1016/j.biotechadv.2019.03.007

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  8 in total

1.  Novel Pneumococcal Protein-Polysaccharide Conjugate Vaccine Based on Biotin-Streptavidin.

Authors:  Mengze Guo; Xiaonan Guo; Chenxing Zhang; Shidong Zhu; Yue Zhang; Tiejun Gu; Wei Kong; Yongge Wu
Journal:  Infect Immun       Date:  2021-10-25       Impact factor: 3.609

2.  Aberrant Thyroid Function Tests in a Patient Taking Biotin Supplements.

Authors:  Zara Latif; Marc J Crupie
Journal:  Cureus       Date:  2019-08-01

Review 3.  Biotinidase Deficiency: Prevalence, Impact And Management Strategies.

Authors:  Ebru Canda; Sema Kalkan Uçar; Mahmut Çoker
Journal:  Pediatric Health Med Ther       Date:  2020-05-04

4.  Graphene field-effect transistor biosensor for detection of biotin with ultrahigh sensitivity and specificity.

Authors:  Shiyu Wang; Md Zakir Hossain; Kazuo Shinozuka; Natsuhiko Shimizu; Shunya Kitada; Takaaki Suzuki; Ryo Ichige; Anna Kuwana; Haruo Kobayashi
Journal:  Biosens Bioelectron       Date:  2020-06-04       Impact factor: 10.618

5.  Supramolecular Enzymatic Labeling for Aptamer Switch-Based Electrochemical Biosensor.

Authors:  Anabel Villalonga; Concepción Parrado; Raúl Díaz; Alfredo Sánchez; Beatriz Mayol; Paloma Martínez-Ruíz; Diana Vilela; Reynaldo Villalonga
Journal:  Biosensors (Basel)       Date:  2022-07-12

6.  Extracellular vesicles on demand (EVOD) chip for screening and quantification of cancer-associated extracellular vesicles.

Authors:  Yoon-Tae Kang; Thomas Hadlock; Shruti Jolly; Sunitha Nagrath
Journal:  Biosens Bioelectron       Date:  2020-08-23       Impact factor: 12.545

7.  Influence of Endogenous Factors of Food Matrices on Avidin-Biotin Immunoassays for the Detection of Bacitracin and Colistin in Food.

Authors:  Maksim A Burkin; Inna A Galvidis; Sergei A Eremin
Journal:  Foods       Date:  2022-01-13

8.  The biotin interference within interference suppressed immunoassays.

Authors:  Payam Kabiri; Ralf Weiskirchen; Josef van Helden
Journal:  J Clin Lab Anal       Date:  2021-08-04       Impact factor: 2.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.